Status:

RECRUITING

RSV Vaccine in Transplant Recipients

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

The PSI Foundation, Ontario

University of British Columbia

Conditions:

Vaccine Response Impaired

Respiratory Syncytial Virus Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Adjuvant, non-live RSV vaccine will be administered to adult lung and allogeneic hematopoietic stem cell transplant recipients. The safety and immunogenicity of this intervention will be studied. Bloo...

Detailed Description

This is a single-arm, open-label, investigational and interventional study to determine the immunogenicity of one dose of RSV vaccine in adult Allogeneic Stem Cell Transplant (alloSCT) or lung transpl...

Eligibility Criteria

Inclusion

  • Stable outpatient lung transplant recipients more than 3 months post-transplantation and stable outpatient allogeneic HCT recipients more than 6 months post-transplantation
  • Adult equal or over 18 years of age
  • Able to comply with blood work at 4-6 weeks post-vaccination
  • Able to provide informed consent

Exclusion

  • Currently pregnant or planning to conceive or breastfeeding
  • IVIg or plasmapharesis in last 30 days or expecting in next 30 days
  • Previous rituximab in last 6 months
  • Active CMV infection with VL \> 1000 IU/ml
  • Diagnosis of RSV in the past 90 days
  • Unwell with acute infection (respiratory or other)
  • Any vaccination in last 2 weeks
  • History of severe allergic reaction (anaphylaxis) to any vaccination
  • Active rejection in last 30 days for lung transplant recipient
  • Active GvHD or poor graft function for alloSCT recipient

Key Trial Info

Start Date :

October 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06593210

Start Date

October 1 2024

End Date

March 1 2026

Last Update

November 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Network

Toronto, Canada

RSV Vaccine in Transplant Recipients | DecenTrialz